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We isolated an iron-uptake mutant of Neisseria meningitidis M986-NCV-1 that was severely limited in the
ability to use several sources of iron in the form of Fe3+. This mutant, FAM1l, grew poorly or not at all with
human transferrin (TF) or lactoferrin (LF) as the sole iron source in a defined medium but grew as well as
wild-type meningococci with hemin or hemoglobin. Uptake of 55Fe bound to TF, LF, dicitrate complexes,
aerobactin, or nitrilotriacetate was reduced to 0 to 4% of the wild-type level. FAMll did not produce an
iron-repressible outer membrane protein (FeRP) of 70 kilodaltons (kDa) found in membranes of iron-stressed
M986-NCV-1. Western blot (immunoblot) analysis using rabbit antiserum against this protein revealed that at
least 17 of 18 meningococcal and 10 of 14 gonococcal strains produced an FeRP of ca. 70 kDa. The 70-kDa FeRP
was shown to be surface exposed by radioimmunoprecipitation with human immune sera. These data suggest
that the 70-kDa FeRP is somehow involved in Fe uptake from TF and LF. However, we were unable to
transform the iron-uptake phenotype from FAMli into wild-type meningococci to confirm this. Revertants of
FAM1l that grew with TF and LF did not regain the ability to make the 70-kDa FeRP but also did not
completely regain the Fe-uptake phenotype of M986-NCV-1.
The ability to obtain iron (Fe) from the infected host is an
important determinant in infection caused by many bacterial
pathogens (30). The work of Holbein and co-workers with
experimentally infected mice suggested that this is also true
for Neisseria meningitidis (14-17), since the availability of
transferrin (TF)-bound Fe was correlated with the progress
of meningococcemia in these mice (14-16). Mice pretreated
with an injection of iron dextran or Fe-TF developed a lethal
septicemia when subsequently injected with meningococci,
whereas mice injected with bacteria alone were only tran-
siently bacteremic (14). This transient meningococcemia
coincided with the kinetics of the hypoferremic response in
these infected mice (14), suggesting that the ability to use
Fe-TF for growth was critical to the ability of N. meningiti-
dis to multiply in the bloodstream (14). Although N. menin-
gitidis is capable of using exogenous aerobactin for growth
(33), the organism does not produce siderophores (1, 28), as
do many other bacteria. Instead, meningococci remove Fe
directly from host Fe sources such as Fe-TF or Fe-lacto-
ferrin (Fe-LF) (1, 28).
We have used the bactericidal action of streptonigrin
(SNG) to isolate meningococcal Fe-uptake mutants (7a). Our
strategy was based on the observations of Yeowell and
White (34), who showed that the bactericidal effect of SNG
on Escherichia coli depended on intracellular Fe levels.
Bacteria with low intracellular Fe levels were relatively
resistant to SNG, whereas Fe-replete organisms were rap-
idly killed by the drug (34). We found that SNG killing of
meningococci was similarly affected by intracellular Fe (7a),
and SNG could be used to enrich for meningococcal Fe-
uptake mutants (7a). A culture of actively growing bacteria
treated with SNG in the presence of a particular Fe source
(such as Fe-TF) yielded survivors enriched for mutants
incapable of using that Fe source (7a). Here we present an
analysis of a meningococcal iron-uptake mutant which is
impaired in the ability to use nonheme Fe for growth.
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MATERIALS AND METHODS
Bacteria, growth conditions, and isolation of mutant. N.
meningitidis M986-NCV-1, a nonencapsulated derivative of
strain M986 (10), was used in this study; M986 is serogroup
B, serotype 2a. Meningococci were routinely maintained on
GCB agar (Difco Laboratories), containing Kellogg supple-
ments I and 11 (18), at 37°C in a 5% CO2 atmosphere. To
assess growth with a specific Fe source, we used an iron-
depleted defined medium, designated CDM, which was
previously described (32). Glassware was washed with acid
to remove contaminating Fe (25). CDM agar plates were
prepared by the addition of sterile molten agarose to a final
concentration of 1%. To examine the kinetics of growth in
liquid culture, meningococci were grown overnight on CDM
agar, suspended in CDM broth, and grown to the mid-to-late
log phase. These cells were then diluted into prewarmed
CDM supplemented with an Fe source of interest. Growth
was monitored by optical density by using a Klett-Sum-
merson colorimeter with a green filter.
Strain FAM11 was isolated from an ethyl methanesulfo-
nate-mutagenized culture of M986-NCV-1 after SNG enrich-
ment and in plate assays was unable to use Fe-TF for
growth. The details of ethyl methanesulfonate mutagenesis
and SNG enrichment have been described (7a). Briefly,
meningococci treated with ethyl methanesulfonate were
grown to the late log phase in a medium containing human
Fe-TF as the sole source of Fe. SNG (final concentration, 1
,ug/ml) was then added to the culture to kill wild-type
Fe-replete meningococci; FAMll was identified as a survi-
vor which did not use Fe-TF for growth in plate assays.
Iron sources. Human TF and LF were obtained from
Sigma Chemical Co. and were at least 98% pure according to
the supplier. Preparation of Fe-loaded forms of these pro-
teins has previously been described (24, 25). Aerobactin
(provided by S. E. H. West) was purified by the method of
Bindereif (A. Bindereif, M. S. thesis, University of Califor-
nia, Berkeley, 1980) and made 50% saturated with "Fe.
55Fe-nitrilotriacetate (NTA) complexes were prepared by
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adding a twofold molar excess of sodium NTA to "FeCl3.
Determination of Fe uptake from "Fe-labeled Fe sources
was performed as previously described (Dyer et al., in
press). "FeCl3 was from New England Nuclear Corp.; the
specific activity of the "Fe was 235 cpm/pmol.
Heme was prepared fresh daily in 10 mM NaOH. Human
hemoglobin (Hb) A (Sigma) was also prepared fresh daily, in
10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-etha-
nesulfonic acid) (pH 7.4). In some experiments, the growth
medium was supplemented with 10% heat-inactivated (56°C
for 30 min) human serum obtained from a pool of volunteers
with no known overt disease caused by N. meningitidis or
Neisseria gonorrhoeae. Protein concentration was measured
by the method of Bradford (5), using the Bio-Rad protein
assay, and Fe concentration was estimated by using the
ferrozine reagent (29).
Analysis of membrane proteins. Sarcosyl-insoluble outer
membranes were isolated and examined by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
(31). Western blots (immunoblots) were performed as de-
scribed by Black et al. (4), using rabbit antiserum prepared
against the 70-kilodalton (kDa) iron-repressible outer mem-
brane protein (FeRP) purified by preparative SDS-PAGE (4).
Colony immunoblots were used in some experiments to
detect production of the 70-kDa FeRP in meningococcal
colonies. To do this, colony lifts were made by placing a
Millipore HATF nitrocellulose filter (diameter, 47 mm) over
meningococcal colonies growing on CDM agar. After 30
min., the nitrocellulose was placed colony side up on What-
man 3MM filter paper soaked in 0.1 M NaHCO3-1%
SDS-100 p,g of lysozyme per ml. The cells were lysed with
CHCl3 vapors at room temperature for 30 min; the colony lift
was then placed onto a second filter soaked with 0.1 M
NaHCO3-0.1% SDS and baked for 1 h at 68°C. The nitro-
cellulose filter was then probed with rabbit anti-70-kDa
FeRP serum as described for Western blots (4). This heat
and detergent treatment was necessary to denature the
antigen sufficiently to react with the rabbit antiserum (data
not shown).
Radioimmunoprecipitation. Log-phase, Fe-stressed me-
ningococci were concentrated by centrifugation and sus-
pended in modified Dulbecco PBS (137 mM NaCI, 2.7 mM
KCl, 8 mM Na2HPO4 .7H20, 7.35 mM KH2PO4, 0.25 mM
CaCl2, 1.0 mM MgCl2 [pH 7.4]). The cells were then surface
labeled by radioiodination with 500 pCi of carrier-free Na1251
(Amersham Corp.), using lodobeads (Pierce Chemical Co.)
as described by Markwell (22). The cells were washed three
times with PBS by centrifugation in an Eppendorf Micro-
fuge. The radiolabeled cells were then used in radioimmu-
noprecipitation essentially as described by Hansen et al.
(13). Radioiodinated cells (approximately 107 cpm) were
added to an Eppendorf tube containing 400 ,ul of PBS with
5% fetal calf serum. This mixture was incubated for 10 min
at room temperature, followed by the addition of a 50- to
100-pI sample of normal human serum or serum obtained
from an individual convalescing from disseminated neisserial
infection. The radioiodinated cells and antiserum were then
incubated at 4°C for 90 min with gentle mixing. The cells
were pelleted and washed once with 1 ml of cold PBS to
remove unbound antibody and suspended in 1 ml of triple
detergent buffer (TD buffer) (0.1% SDS, 0.2% sodium de-
oxycholate, 1.0% Triton X-100, 10 mM Tris hydrochloride
[pH 7.8]); the cells were lysed at 37°C for 1 h with occasional
vigorous mixing to disperse clumps of cells. The lysate was
then centrifuged for 30 min in a Microfuge at room temper-
ature. The supernatant was carefully removed, and a portion
was saved for SDS-PAGE analysis. A 100-,ul portion of
IgGSorb (The Enzyme Center, Inc., Malden, Mass.) in TD
buffer was added to the remainder and mixed gently for 10
min. Before use, the IgGSorb was incubated with lysed
nonradioactive meningococci to block nonspecific binding of
meningococcal antigens to the immunosorbent.
After adsorbing antigen-antibody complexes, the IgGSorb
was washed by centrifugation six times in 1.0 ml of TD
buffer. The final pellet was suspended in 100 RI of SDS-
PAGE solubilizing buffer and boiled for 5 min, and the
IgGSorb was removed by centrifugation. The supernatant,
containing immunoprecipitated radiolabeled meningococcal
cell surface antigens, was electrophoresed on a 10 or 15%
SDS-polyacrylamide gel; radioiodinated proteins were iden-
tified by autoradiography of the dried gel.
Genetic procedures. Transforming DNA was isolated from
meningococci as described by Marmur (23), and meningo-
cocci were transformed as described for N. gonorrhoeae by
Sarubbi et al. (27). Streptomycin-resistant transformants
were selected on GCB plates containing 100 pRg of antibiotic
per ml.
RESULTS
Growth kinetics. In preliminary plate assays, FAM11 did
not grow with Fe-TF or Fe-LF as the sole source of Fe in
CDM agar. In liquid CDM, strain M986-NCV-1 grew rapidly
and to a high final cell density with Fe-TF as the sole source
of Fe (Fig. 1), whereas FAM11 grew poorly (Fig. 1). The
Fe-TF concentration in this experiment was 30 ,uM and the
Fe-binding capacity was 25% saturated, which approximates
physiological conditions (30). Similarly, FAM11 was unable
to grow when CDM was supplemented with 13 ,uM Fe-LF
(5% saturated) or 10% heat-inactivated normal human serum
(data not shown), although these conditions supported rapid
and extensive growth of M986-NCV-1. However, FAM11
grew as well as the parent strain with heme as the sole source
of Fe in CDM (Fig. 2); similar results were obtained with Hb
(data not shown), indicating that heme and Hb utilization by
FAM11 was unimpaired, even though growth with Fe-TF
and Fe-LF was dramatically reduced.
55Fe uptake. The data for "Fe uptake are presented in
Table 1. Whereas strain M986-NCV-1 was capable of rapidly
internalizing large amounts of "Fe bound to TF in an
energy-dependent manner (Table 1), we were unable to
detect any net 55Fe accumulation by FAM11 from TF above
the 55Fe bound to KCN-poisoned cells, which do not inter-
nalize Fe (2, 28). Similarly, we were unable to detect the
uptake of "5Fe by FAM11 when the Fe was bound to LF,
under conditions in which the uptake of "sFe from 5%-
saturated LF by M986-NCV-1 was detectable. We used
5%-saturated LF in these experiments to approximate the
low level of Fe found on LF in vivo (9). Using higher
concentrations of "sFe bound to 13 puM LF increased the
amount of "sFe internalized by M986-NCV-1 from LF, but
uptake of "sFe from LF by FAM11 was still undetectable
(data not shown).
Meningococci also internalize 5"Fe from dicitrate com-
plexes (2); citrate is not internalized (2), similar to what
occurs in the citrate-inducible Fe-uptake system in E. coli
(11). However, unlike uptake by E. coli (11), citrate-depen-
dent Fe uptake by meningococci does not depend on induc-
tion by citrate (2). We found that FAM11 internalized only
about 2% of the amount of "5Fe taken up by M986-NCV-1
from 1 ,uM Fe-dicitrate (Table 1). Increasing the concentra-
tion of 55Fe-dicitrate to 10 puM yielded similar results (data
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FIG. 1. Inability of FAM11 to grow with human Fe-TF. Log-
phase M986-NCV-1(0) or FAM11 (A) cells were diluted into CDM
supplemented with 30 ,uM human Fe-TF (25% saturated), and
growth was monitored by optical density.
not shown). This residual level of 55Fe uptake by FAM11
was not inhibited by NTA (Table 1), indicating that the
low-level Fe uptake by FAM11 was not via a low-affinity
NTA-inhibitable uptake system, like that found in E. coli
(11). Since meningococci have been shown to use the
dihydroxamate siderophore aerobactin for growth (33), we
determined the amount of 55Fe taken up by M986-NCV-1
and FAM11 from this Fe source. FAM11 internalized ap-
proximately 1% of the amount of 55Fe from aerobactin taken
up by M986-NCV-1. Taken together, the Fe-uptake data
suggested that FAM11 was impaired in the ability to take up
55Fe from any Fe3+ source that we examined. Since 55Fe-
heme is not commercially available, we did not determine
how efficiently FAM11 internalizes 55Fe from this source.
However, the wild-type growth ofFAM11 with heme (Fig. 2)
and Hb (data not shown) suggests that heme Fe utilization is
unimpaired.
FAMll lacks a 70-kDa FeRP. In many bacteria, Fe-
regulated outer membrane proteins (OMPs) are often in-
volved as OM components of high-affinity Fe-uptake sys-








FIG. 2. Growth kinetics of M986-NCV-1 (0) and FAM11 (A)
with 5 ,uM heme in CDM. The slight reduction in the doubling time
of log-phase FAM11 in this experiment is not significant. In other
experiments, the growth of FAM11 equaled or exceeded that of
M986-NCV-1, suggesting that the growth of FAM11 with heme is
equivalent to that of the wild type.
CDM or CDM plus 100 ,uM Fe(NO3)3 and compared the
OMP profiles of the mutant with the OMPs of wild-type
meningococci grown similarly (Fig. 3). The OM of strain
M986-NCV-1 grown under Fe-limiting conditions contained
FeRPs of 37, 70, 75, and ca. 105 kDa (Fig. 3, arrows). In
contrast, membranes of FAM11 lacked the prominent 70-
kDa FeRP found in M986-NCV-1; additionally, the remain-
ing FeRPs were expressed constitutively rather than regu-
lated by Fe limitation. When reacted with rabbit antiserum
directed against the 70-kDa FeRP (4), whole-cell lysates of
FAM1l did not possess any immunoreactive material as
assessed by either Western blot or colony immunoblot (data
not shown). Thus, FAM1l did not produce detectable 70-
kDa FeRP.
Recently, van Putten (Proc. 5th Int. Pathog. Neisseria
Conf., abstr. V-131, 1986) used chemostat cultures to show
that certain meningococcal OMPs are synthesized in re-
sponse to lowered growth rate; such proteins were termed
GSPs (growth-rate-sensitive proteins). Since Fe starvation
also slows meningococcal growth, we wondered whether the
TABLE 1. "Fe uptake by M986-NCV-1 and FAMll
"Fe uptake (pmol/108 CFU per 30 min) from iron source:
Strain Fe-TF (30 F.M, Fe-LF (13 F.M, Fe-dicitrate Fe-aerobactin Fe-NTA
26% saturated) 5% saturated) (1 pM Fe) (10 pM Fe) (1 pM Fe)
M986-NCV-1 439.7 19.2 508.6 1,614.5 149.6
FAMll 0 0 9.8 (1.9%)a 21.3 (1.3%) 6.2 (4.1%)
a Percentage of uptake by M986-NCV-1.
VOL. 56, 1988
980 DYER ET AL.
M986-
NCV-I FAMll







Fe + - +
FIG. 3. SDS-PAGE of meningococcal OMPs. M986-NCV-1 and
FAM11 were grown in CDM or CDM supplemented with 100 ,uM
Fe(NO3)3, and sarcosyl-insoluble OMs were prepared, electropho-
resed on a 10% SDS-polyacrylamide gel, and stained with Coomas-
sie brilliant blue (31). FeRPs produced by M986-NCV-1 are identi-
fied by the arrows. The FeRPs were constitutively produced by
FAM11, except for the 70-kDa FeRP, which was missing. The
migration of molecular mass standards is shown on the right. kdal,
Kilodaltons.
70-kDa FeRP is regulated not by Fe stress but by changes in
growth rate. Consequently, we slowed the growth of M986-
NCV-1 by manipulating pH, temperature, or aeration and
saw no appreciable effect on the synthesis of the 70-kDa
protein. A typical result is presented in Fig. 4, which shows
the growth of M986-NCV-1 in CDM at 37°C in a 5% CO2
atmosphere when the organism was incubated either in static
cultures (low aeration) or shaken vigorously at 250 to 300
rpm (high aeration). In rapidly shaken cultures, CDM sup-
plemented with 100 ,uM Fe(NO3)3 supported rapid meningo-
coccal growth and meningococci grew to a much greater final
optical density than in CDM. Without vigorous aeration,
M986-NCV-1 grew at essentially the same rate in CDM or
CDM plus 100 ,uM Fe(NO3)3. When the relative amounts of
the 70-kDa protein were assessed by Western blot, only
those cultures deprived of Fe produced measurable amounts
of the protein (Fig. 4, inset, and data not shown). Similar
results were obtained with meningococci grown at pH 6.6 or
30°C (data not shown). Thus, Fe deprivation but not slow
growth resulted in production of the 70-kDa FeRP.
We attempted to transfer the Fe-uptake deficit of FAM11
back into wild-type meningococci to determine whether the
inability to produce the 70-kDa FeRP was responsible for the
Fe-uptake phenotype. Initial transformations using M986-
NCV-1 or the encapsulated parent, M986 (obtained from C.
Frasch), as the recipient indicated that neither strain was
competent for transformation. We were unable to select
competent derivatives of these strains. Subsequently, we
used a second strain, FAM18, as a recipient in these genetic
crosses. N. meningitidis FAM18 is a serogroup C, serotype
2a strain that we have used in other experiments (7a); it
makes a 70-kDa FeRP that cross-reacts immunologically
with the 70-kDa FeRP of M986-NCV-1 (data not shown).
Since SNG may be mutagenic in the neisseriae (7a) we chose
to do this transformation by congression rather than after
SNG enrichment. We first isolated a spontaneous Strr mu-
tant of FAM11; after transforming FAM18 for Strr by using
saturating concentrations of DNA (1 ,ug/ml), 2,019 trans-
formants were transferred individually with toothpicks to
GCB, CDM-TF, and CDM-LF plates to identify recipients
that had received the TF- phenotype. Although Strr trans-
formants of FAM18 were obtained at a frequency of ca.
10-4, we did not identify any transformant that had lost the
ability to use Fe-TF or Fe-LF for growth. Thus, we were not
able to determine whether the loss of the 70-kDa FeRP was
directly responsible for the Fe-uptake phenotype of FAM11.
We also looked for revertants of FAM11 which were able
to use Fe-TF and Fe-LF for growth to determine whether
restoration of the ability to use these Fe sources coincided
with renewed expression of the 70-kDa FeRP. This was done
by plating FAM11 onto CDM plates containing 5 ,uM apo-TF
or apo-LF; revertant colonies able to use these Fe sources
appeared at a frequency of 3.4 x 10-6 (on TF plates) or 3.9
X 10-6 (on LF plates). We screened 40 TF+ revertants of
FAM11 and found that each had regained the ability to use
Fe-LF for growth; similarly, each of 40 tested LF+ rever-
tants grew with Fe-TF as the sole Fe source. None of these
revertants, however, appeared to synthesize the 70-kDa
FeRP, as assayed by colony immunoblot (data not shown).
We also probed colony blots of FAM11 grown on CDM agar
in an attempt to identify directly spontaneous revertants that
had regained the ability to synthesize the 70-kDa FeRP. This
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FIG. 4. Growth conditions and production of the 70-kDa FeRP.
Strain M986-NCV-1 was grown in CDM (--- - -) or CMD plus 100
,uM Fe(NO3)3 (-) with vigorous aeration (0) or in static culture (0).
At the times indicated by the arrows, cells were removed from each
culture and assayed for production of the 70-kDa FeRP by Western
blot. The inset shows the results of a Western blot of cells taken at
6.5 h; later times gave similar results.
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also was unsuccessful in identifying revertants of FAMll
that produced the 70-kDa FeRP. Thus, we were unable to
associate directly the ability to produce the 70-kDa FeRP
with the ability to use TF and LF as Fe sources.
Closer examination of selected TF+ and LF+ revertants,
however, suggested that these strains did not regain wild-
type growth kinetics with protein-bound Fe. The kinetics of
growth in CDM supplemented with Fe-TF (Fig. 5) indicated
that FAM63 (a TF+ LF+ revertant of FAM1l) did not grow
as efficiently as strain M986-NCV-1 with 30 F.M Fe-TF (25%
saturated); similar results were obtained with CDM supple-
mented with Fe-LF or inorganic Fe (data not shown). With
each Fe source, FAM63 demonstrated at least a 1-h lag
before growth commenced, and cultures of FAM63 did not
reach the same final optical density as that of M986-NCV-1
cultures; log-phase doubling times of the revertant and
M986-NCV-1 were identical, however. Similar results were
obtained with three other independently isolated revertants
(data not shown). We next compared the "Fe uptake of
FAM63 to that of M986-NCV-1. FAM63 internalized 37% of
the "Fe taken up by M986-NCV-1 from Fe-TF in 30 min.
"Fe uptake from LF and dicitrate complexes was also
reduced (65 and 81%, respectively, of the wild-type level at
30 min). This reduction in "Fe uptake and the altered growth
kinetics of FAM63 (Fig. 5) suggested that this and other
revertants had not regained wild-type ability to use Fe-TF
and Fe-LF for growth; these revertants may constitute
extragenic suppressors of the original TF-/LF- mutation in
FAM11. We also examined the OMP profile of four rever-
tants and found them to be identical. In each instance, no
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FIG. 5. Growth of TF+ revertant FAM63 with human Fe-TF.
Log-phase M986-NCV-1 (0), FAM63 (O), and FAM11 (A) cells
were diluted into CDM containing 30 p.M Fe-TF (25% saturated).
Although FAM63 grew well with Fe-TF, it did not display wild-type
kinetics. The growth of FAM63 with Fe-LF or Fe-dicitrate was
similarly reduced compared with that of M986-NCV-1.







FIG. 6. Radioimmunoprecipitations of meningococcal OMPs
with human convalescent-phase sera. Strain M986-NCV-1 was
radioiodinated after growth in CDM or CDM plus 100 F.M Fe(NO3)3;
radioimmunoprecipitations were then performed as described in the
text, the immunoprecipitates were electrophoresed on a 10% SDS-
polyacrylamide gel, and an autoradiogram was made of the dried
gel. The migration of molecular mass markers (masses indicated in
kilodaltons) is shown on the right. Lanes: 1, PBS control; 2, normal
human serum control; 3, convalescent-phase serum from a patient
with meningococcemia; 4, convalescent-phase serum from a patient
recovering from disseminated gonococcal infection; 5 and 6, rad-
ioiodination profile of Fe-stressed (lane 5) and Fe-replete (lane 6)
strain M986-NCV-1.
were constitutively produced in the OM of FAM11 (Fig. 3)
regained the Fe regulation observed in M986-NCV-1 (data
not shown).
The 70-kDa FeRP is a common, surface-exposed antigen. It
was shown that the 70-kDa FeRP elicits antibody in infected
humans (4). We used convalescent-phase sera from patients
recovering from meningococcal or gonococcal disease to
examine the surface exposure of the 70-kDa FeRP by
radioimmunoprecipitation (Fig. 6). Radioiodination of whole
cells of M986-NCV-1 resulted in incorporation of 125I into
the 70-kDa protein (Fig. 6, lane 5, arrow), but this may not
directly indicate surface exposure (21). However, convales-
cent-phase serum from a patient recovering from dissemi-
nated gonococcal infection (Fig. 6, lane 4) or from meningo-
coccal infection (Fig. 6, lane 3) immunoprecipitated the
70-kDa FeRP; the amounts of immunoprecipitable 70-kDa
FeRP varied but were always greater than for a PBS or
normal human serum control (Fig. 6, lanes 1 and 2, respec-
tively). These results suggest that the protein is surface
exposed and further indicate that the protein is cross-
reactive betweep meningococcal and gonococcal strains. We
previously showed that each of four tested meningococcal
strains produced a 70-kDa FeRP that cross-reacted with
antiserum directed against the protein made by N. menin-
gitidis FAM20 (4). Using Western blots, we found that an
additional 17 of 18 meningococcal strains and 10 of 14
gonococcpl strains produced an FeRP of approximately 70
kDa (data not shown). Recently, one of us (W.M.) has
observed that convalescent-phase sera from two patients
recovering from disseminated gonococcal infection con-
tained immunoglobulin G antibodies against the 70-kDa
FeRP, although the gonococcal strains isolated from these
patients did not produce the 70-kDa FeRP when Fe stressed
in vitro. All tested meningococci and gonococci used TF for
growth in vitro (25); all tested meningococci and 60%o of
gonococcal strains used LF for growth (24). The iron-uptake
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phenotype of a particular strain was not correlated with a
specific group of FeRPs (31). Thus, the prevalence of the
70-kDa FeRP in these pathogens may be underestimated by
the Western blot data, and the role of this protein in Fe
uptake is uncertain. However, it is clear that this antigen is
not only surface exposed but is widespread within the
pathogenic neisseriae.
DISCUSSION
We isolated a pleiotropic meningococcal mutant that was
markedly deficient in uptake of Fe from multiple sources,
including TF, LF, citrate, and aerobactin. It did grow
normally with heme as a sole Fe source, suggesting that
heme Fe utilization occurs through distinct pathways. The
mutant, FAM1l, also made no detectable 70-kDa FeRP,
suggesting that the 70-kDa protein may be involved in uptake
or utilization of Fe from TF, LF, citrate, or aerobactin. The
observation that the 70-kDa FeRP is surface exposed is
consistent with this possibility.
Our inability to transform the mutant phenotype into
wild-type competent meningococci prevented more definite
conclusions about the relationship between the 70-kDa FeRP
and Fe uptake. It is not clear why we were unable to
transform the Fe-uptake-deficient phenotype from FAM11
into FAM18. Using similar techniques, we were able to
transfer an unrelated mutation that results in specific loss of
the ability to use TF as an Fe source into FAM18 (7a); in the
latter instance, the donor and recipient were isogenic,
whereas in the present study the donor (FAM11) was sero-
group B and the recipient (FAM18) was serogroup C. Thus,
it is possible that genetic differences between strains pre-
vented efficient transformation in the present experiments. It
also is possible that FAM11 contains multiple unlinked
mutations, which would markedly impair the ability to
transform the Fe-uptake-deficient phenotype from FAM11
into another strain. This is consistent with the observation
that TF+ and LF+ revertants of FAM11 did not regain
wild-type Fe-uptake ability. There could be other explana-
tions as well. Our results are compatible with the hypothesis
that the 70-kDa FeRP is involved in some manner in Fe3 +
uptake from diverse sources, but better evidence is required,
preferably from introduction of a specific mutation of the
cloned structural gene for the 70-kDa FeRP.
The complicated phenotype of FAM11 is similar in some
respects to that of tonB mutants of E. coli (12). tonB function
is required in E. coli to provide energy for high-affinity Fe3"
uptake from diverse sources, as well as for the uptake of
vitamin B12 (12). We used a cloned E. coli tonB gene to
probe genomic digests of meningococcal or gonococcal
DNA and found no evident homology (E. Rosenberg, un-
published data) under conditions of low stringency which
had been previously used to detect a functional gonococcal
analog of the E. colifluB gene (32).
The biochemical defects in FAMll that prevented the use
of Fe3+ bound to TF, LF, citrate, or aerobactin are uncer-
tain. One possibility is the loss of an Fe reductase active on
extracellular Fe. This is consistent with the observation that
FAM11 appears to grow normally with heme or Hb as the
sole source of Fe; reduction of Fe bound in a porphyrin ring
occurs readily, but the Fe atom remains bound to the heme
moiety (20). The reduction of Fe3+ to Fe2+ is known to favor
the release of Fe from TF (19). Listeria monocytogenes
releases Fe from TF by a reductive mechanism in the
absence of a siderophore (6). Both M986-NCV-1 and FAM11
reduce appreciable amounts of extracellular Fe3+-dicitrate
(data not shown); since meningococci contain an OM cyto-
chrome oxidase (7), this is probably not surprising. The
relationship of this OM cytochrome oxidase to Fe uptake is
not clear. However, A. E. Lefaou and S. A. Morse (Abstr.
Annu. Meet. Am. Soc. Microbiol. 1987, D-20, p. 75) have
found evidence for both cytoplasmic and membrane-bound
Fe3" reductases in gonococci and meningococci; they kindly
examined both M986-NCV-1 and FAM11 for each of these
Fe reductases and found no significant differences between
wild-type and mutant meningococci (data not shown).
The suggestion that a surface-exposed iron-regulated pro-
tein may be critically involved in Fe uptake from TF and LF
is provocative. TF and LF are thought to be the primary Fe
sources for both meningococci and gonococci in vivo (8, 14,
16, 24, 25). This antigen is common to many of the patho-
genic neisseriae that we examined, although not all strains of
N. gonorrhoeae and N. meningitidis expressed a protein
which reacted with our rabbit antiserum. Further studies are
necessary to demonstrate whether this protein is involved in
Fe uptake by N. meningitidis and N. gonorrhoeae.
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